Quantcast

Latest abdominal pain Stories

2014-05-20 20:22:08

DEERFIELD, Ill. and OSAKA, Japan, May 20, 2014 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that the United States (U.S.) Food and Drug Administration (FDA) simultaneously approved a new biologic therapy, Entyvio((TM)) (vedolizumab), for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD). ( ) "Entyvio is a new option that...

2014-05-19 12:31:13

LONDON, May 19, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Needhttp://www.reportbuyer.com/pharma_healthcare/treatments/gastrointestinal_therapeutics_asia_pacific_markets_2019_strong_potential_pipeline_biologics_account_high_regional_unmet_need.htmlGastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong...

2014-05-18 23:02:33

The Gallstone Elimination Report is the latest program that provides people with natural remedies, techniques, tips, and detailed instructions on how to eliminate their gallstones naturally. An overview on the website Vinaf.com shows if the program is good for people to use. Tampa, FL (PRWEB) May 18, 2014 The Gallstone Elimination Report is a new program developed by David Smith, who has many years of experience in the health industry. The program provides people with step-by-step...

2014-05-15 23:09:19

Farshid Rahbar of LA Integrative GI & Nutrition Comments on Study Linking Gut Health to Microbial Diversity Beverly Hills, CA (PRWEB) May 15, 2014 Irritable bowel syndrome (IBS) is a disorder that affects a patient’s large intestine, causing symptoms such as abdominal pain, gas, and most commonly, bloating. In the past, IBS was primarily considered to be a psychological condition brought on by stress and anxiety; however, new research has definitively linked IBS to an imbalance of...

2014-05-15 16:27:54

NEW YORK, May, 15, 2014 /PRNewswire-USNewswire/ -- In an effort to increase their long-standing commitment of improving the lives of those with inflammatory bowel disease (IBD), the Crohn's & Colitis Foundation of America (CCFA) will host the first U.S. IBD2020 meeting from May 16(th)- May 18(th) in New Orleans, LA. http://photos.prnewswire.com/prnvar/20140515/88144 "IBD2020 USA is a critical meeting of some of the brightest minds who are thinking about both IBD and Quality of...

2014-05-13 23:10:01

New Findings for EnteraGam™ (Serum-derived bovine immunoglobulin/protein isolate, SBI) Cary, NC (PRWEB) May 13, 2014 Abigail Henderson, PhD, presented new preclinical data for the prescription medical food, EnteraGam™ (serum-derived bovine immunoglobulin/protein isolate, SBI), demonstrating that the immunoglobulin-based protein mixture in SBI binds and neutralizes two types of toxins (exotoxins A and B) from several ribotypes of C. difficile, including recently isolated strains with...

2014-05-13 00:21:38

- This Is First Study to Demonstrate Clinical Benefit of Oral alpha 4 Integrin Antagonist in Patient with Inflammatory Bowel Disease - TOKYO, May 13, 2014 /PRNewswire/ -- Ajinomoto Pharmaceuticals Co., Ltd. (President, Takashi Nagamachi; Headquarters, Tokyo, Japan) announced on May 13 that the Phase 2a results of an oral alpha 4 integrin antagonist, AJM300, in patients with ulcerative colitis were presented in the Joint Presidential Plenary Session at Digestive Disease Week (DDW)...

2014-05-05 20:24:20

LONDON, May 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Gastrointestinal Therapeutics in Major Developed Markets to 2019 - New Drug Approvals and Promising Pipeline to Counter Declines from Patent Expirieshttp://www.reportbuyer.com/pharma_healthcare/treatments/gastrointestinal_therapeutics_major_developed_markets_2019_new_drug_approvals_promising_pipeline_counter_declines_patent_expiries.htmlGastrointestinal Therapeutics in Major Developed Markets to...

2014-05-05 08:30:08

- The long-term safety profile was consistent with pivotal trials of Cimzia® ATLANTA, May 5, 2014 /PRNewswire/ -- UCB announced today results from the PRECiSE 3 7-year open label extension clinical trial of Cimzia(®) (certolizumab pegol), the longest continuous trial of an anti-TNF therapy evaluating long-term safety in Crohn's disease. Remission was also assessed over the trial period. Results were presented at Digestive Disease Week (DDW), taking place in Chicago from May 3-6. "The...

2014-05-05 08:29:18

ENDOCAPSULE 10 Delivers Outstanding Visualization, Improved Efficiency and Enhanced Features for Noninvasive Observation of the Small Intestine CENTER VALLEY, Pa., May 5, 2014 /PRNewswire/ -- Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, announced today the commercial availability of its 510(k) cleared, next-generation ENDOCAPSULE 10 System for small bowel capsule endoscopy...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'karpos', fruit.
Related